Celemics Past Earnings Performance
Past criteria checks 3/6
There is insufficient data on Celemics's performance over the last few years.
Key information
n/a
Earnings growth rate
n/a
EPS growth rate
| Life Sciences Industry Growth | 53.7% |
| Revenue growth rate | -20.6% |
| Return on equity | 39.4% |
| Net Margin | 181.0% |
| Last Earnings Update | 30 Jun 2024 |
Recent past performance updates
Recent updates
Celemics (KOSDAQ:331920) Is Posting Solid Earnings, But It Is Not All Good News
Aug 26
We're Not Very Worried About Celemics' (KOSDAQ:331920) Cash Burn Rate
Jul 29Here's Why We're Not Too Worried About Celemics' (KOSDAQ:331920) Cash Burn Situation
Mar 28What You Need To Know About Celemics, Inc.'s (KOSDAQ:331920) Investor Composition
Dec 17Revenue & Expenses Breakdown
How Celemics makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Jun 24 | 6,082 | 11,010 | 4,929 | 997 |
| 31 Mar 24 | 6,527 | -3,025 | 5,343 | 1,139 |
| 31 Dec 23 | 6,578 | -3,876 | 5,629 | 1,308 |
| 31 Dec 22 | 8,729 | -4,797 | 5,548 | 2,211 |
| 31 Dec 16 | 1,554 | -5,875 | 2,494 | 1,928 |
| 31 Dec 15 | 742 | -3,112 | 1,713 | 741 |
Quality Earnings: A331920 has a high level of non-cash earnings.
Growing Profit Margin: A331920 became profitable in the past.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: A331920 has become profitable over the past 5 years.
Accelerating Growth: A331920 has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.
Earnings vs Industry: A331920 has become profitable in the last year, making it difficult to compare its past year earnings growth to the Life Sciences industry (18%).
Return on Equity
High ROE: A331920's Return on Equity (39.4%) is considered high.